The Capital Builder The Capital Builder
  • Business
  • Investing
  • Politics
  • Stocks
  • Latests news
Investing

RAD Granted US FDA Fast Track for RAD101 Metastases Imaging

June 11, 2025
Share
Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD Granted US FDA Fast Track for RAD101 Metastases Imaging

Download the PDF here.

This post appeared first on investingnews.com

0
Prev Post

Rapid Increases Land Holding by 26 X

June 11, 2025
Next Post

Hyundai Builds Rare Earths Stockpile to Offset Supply Risks

June 11, 2025

Related Posts

Greenland Lithium Pegmatite Field Significantly Expanded by Brunswick Exploration

August 13, 2025

International Lithium Announces Private Placement

August 13, 2025

Strategic EL Secured -Expands Control of NSW Silver Corridor

August 13, 2025

      Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


      By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.


        • About us
        • Privacy Policy
        • Terms & Conditions

      Copyright © 2024 TheCapitalBuilder.com. All Rights Reserved.

      • Business
      • Investing
      • Politics
      • Stocks
      • Latests news